Cargando…

Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing

BACKGROUND: Craniopharyngioma (CP) is rare histologically benign but clinically challenging tumor because of its intimate relationship with the critical structure in the central brain. CP can be divided into two major histologic subtypes: adamantinomatous-type CP (ACP) and papillary-type CP (PCP). A...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Juan, Zeng, Zhen, Wang, Yuelong, Deng, Jiaojiao, Tang, Xin, Liu, Fujun, Huang, Jianhan, Chen, Hongxu, Liang, Ruichao, Zan, Xin, Liu, Zhiyong, Tong, Aiping, Guo, Gang, Xu, Jianguo, Zhu, Xiaofeng, Zhou, Liangxue, Peng, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684236/
https://www.ncbi.nlm.nih.gov/pubmed/34922552
http://dx.doi.org/10.1186/s12943-021-01468-7
_version_ 1784617577758064640
author He, Juan
Zeng, Zhen
Wang, Yuelong
Deng, Jiaojiao
Tang, Xin
Liu, Fujun
Huang, Jianhan
Chen, Hongxu
Liang, Ruichao
Zan, Xin
Liu, Zhiyong
Tong, Aiping
Guo, Gang
Xu, Jianguo
Zhu, Xiaofeng
Zhou, Liangxue
Peng, Yong
author_facet He, Juan
Zeng, Zhen
Wang, Yuelong
Deng, Jiaojiao
Tang, Xin
Liu, Fujun
Huang, Jianhan
Chen, Hongxu
Liang, Ruichao
Zan, Xin
Liu, Zhiyong
Tong, Aiping
Guo, Gang
Xu, Jianguo
Zhu, Xiaofeng
Zhou, Liangxue
Peng, Yong
author_sort He, Juan
collection PubMed
description BACKGROUND: Craniopharyngioma (CP) is rare histologically benign but clinically challenging tumor because of its intimate relationship with the critical structure in the central brain. CP can be divided into two major histologic subtypes: adamantinomatous-type CP (ACP) and papillary-type CP (PCP). Although some genetic aberrations for both categories have been revealed in previous studies, the complete spectrum of genetic changes of this tumor remains unknown. METHODS: In this study, we conducted whole genome sequencing (WGS) on twenty-six CPs including 16 ACPs and 10 PCPs together with their matched blood samples. Somatic variants (SNVs, InDels, SVs and CNVs) were identified and mutational signatures were characterized for each patient. We investigated the impact of a novel CTNNB1 mutant on its protein stability, ubiquitination and Wnt pathway activity. Cell proliferation ability of the CTNNB1 mutant in ACP primary cells was additionally analyzed by CCK8 and colony formation assays. RESULTS: We found that CPs had showed less complexity with fewer somatic mutations compared with malignant tumors. Moreover, mutations in CTNNB1 (68.75% of ACP) and BRAF V600E (70.00% of PCP) are mutually exclusive in ACP and PCP, consolidating that the driving roles of these two genes in ACP and PCP, respectively. A novel mutation in the exon 3 of CTNNB1 which compromised both a transversion and in-frame deletion was identified in ACP. This mutation was experimentally validated to confer β-catenin increased stability by inhibiting its ubiquitination, thus activating Wnt-signaling pathway and promoting cell proliferation. CONCLUSIONS: Whole genome landscape for CP was revealed by WGS analysis, and a novel mutation in the exon 3 of CTNNB1 was identified. This novel mutation activates Wnt-signaling pathway through increasing the stability of β-catenin. Our findings provided us with more comprehensive insight into the spectrum of genetic alterations in CP. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-021-01468-7.
format Online
Article
Text
id pubmed-8684236
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86842362021-12-20 Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing He, Juan Zeng, Zhen Wang, Yuelong Deng, Jiaojiao Tang, Xin Liu, Fujun Huang, Jianhan Chen, Hongxu Liang, Ruichao Zan, Xin Liu, Zhiyong Tong, Aiping Guo, Gang Xu, Jianguo Zhu, Xiaofeng Zhou, Liangxue Peng, Yong Mol Cancer Research BACKGROUND: Craniopharyngioma (CP) is rare histologically benign but clinically challenging tumor because of its intimate relationship with the critical structure in the central brain. CP can be divided into two major histologic subtypes: adamantinomatous-type CP (ACP) and papillary-type CP (PCP). Although some genetic aberrations for both categories have been revealed in previous studies, the complete spectrum of genetic changes of this tumor remains unknown. METHODS: In this study, we conducted whole genome sequencing (WGS) on twenty-six CPs including 16 ACPs and 10 PCPs together with their matched blood samples. Somatic variants (SNVs, InDels, SVs and CNVs) were identified and mutational signatures were characterized for each patient. We investigated the impact of a novel CTNNB1 mutant on its protein stability, ubiquitination and Wnt pathway activity. Cell proliferation ability of the CTNNB1 mutant in ACP primary cells was additionally analyzed by CCK8 and colony formation assays. RESULTS: We found that CPs had showed less complexity with fewer somatic mutations compared with malignant tumors. Moreover, mutations in CTNNB1 (68.75% of ACP) and BRAF V600E (70.00% of PCP) are mutually exclusive in ACP and PCP, consolidating that the driving roles of these two genes in ACP and PCP, respectively. A novel mutation in the exon 3 of CTNNB1 which compromised both a transversion and in-frame deletion was identified in ACP. This mutation was experimentally validated to confer β-catenin increased stability by inhibiting its ubiquitination, thus activating Wnt-signaling pathway and promoting cell proliferation. CONCLUSIONS: Whole genome landscape for CP was revealed by WGS analysis, and a novel mutation in the exon 3 of CTNNB1 was identified. This novel mutation activates Wnt-signaling pathway through increasing the stability of β-catenin. Our findings provided us with more comprehensive insight into the spectrum of genetic alterations in CP. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-021-01468-7. BioMed Central 2021-12-18 /pmc/articles/PMC8684236/ /pubmed/34922552 http://dx.doi.org/10.1186/s12943-021-01468-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
He, Juan
Zeng, Zhen
Wang, Yuelong
Deng, Jiaojiao
Tang, Xin
Liu, Fujun
Huang, Jianhan
Chen, Hongxu
Liang, Ruichao
Zan, Xin
Liu, Zhiyong
Tong, Aiping
Guo, Gang
Xu, Jianguo
Zhu, Xiaofeng
Zhou, Liangxue
Peng, Yong
Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing
title Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing
title_full Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing
title_fullStr Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing
title_full_unstemmed Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing
title_short Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing
title_sort characterization of novel ctnnb1 mutation in craniopharyngioma by whole-genome sequencing
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684236/
https://www.ncbi.nlm.nih.gov/pubmed/34922552
http://dx.doi.org/10.1186/s12943-021-01468-7
work_keys_str_mv AT hejuan characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing
AT zengzhen characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing
AT wangyuelong characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing
AT dengjiaojiao characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing
AT tangxin characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing
AT liufujun characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing
AT huangjianhan characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing
AT chenhongxu characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing
AT liangruichao characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing
AT zanxin characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing
AT liuzhiyong characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing
AT tongaiping characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing
AT guogang characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing
AT xujianguo characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing
AT zhuxiaofeng characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing
AT zhouliangxue characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing
AT pengyong characterizationofnovelctnnb1mutationincraniopharyngiomabywholegenomesequencing